Long-term study of people treated with Dezawa MuseCells® stem cell therapy

You may qualify if

• Received Dezawa MuseCells® as Part of Routine Clinical Care
• Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.
• Willingness to Complete Online Survey Assessments
• Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.
• Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions.
• Ability to Communicate in the Registry's Supported Language
• Participants must be able to read and respond to registry surveys in the designated study language.
• Enrollment Within 12 Months of MuseCell® Administration

You can't join if

• Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.
• Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.
• Inability to Participate in Long-Term Digital Follow-Up
• Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes
• History of Malignancy Diagnosed Within the Past 12 Months
• Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns.
• Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality
• Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods.
• Pregnant or Actively Breastfeeding at Time of Enrollment